DalsnaFinance

Braveheart Bio targets $1.2 billion valuation in US IPO

Markets Investing.com By Reuters 30 Jul 2026 14:49 1 min read
Braveheart Bio targets $1.2 billion valuation in US IPO

Braveheart Bio targets $1.2 billion valuation in US IPO

Braveheart Bio targets $1.2 billion valuation in US IPO

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.